Expert Adviser:

Sarah’s background, including a Ph.D. in chemical and systems biology from Stanford University and years in drug development, and deep commitment to her clients in Renal Cell Carcinoma (RCC) are evident in her deep, broad, and accurate insights. Through the ONCrg Advisory services, you can contact Sarah directly for personalized answers to non-proprietary questions, targeted analyses, and custom insights in RCC.   More

NSCLC Oncology Resources

Medical Conference Coverage:

ONCrg Conference reports deliver expert analysis of the noteworthy scientific, clinical, and commercial changes presented at major medical conferences such as ASCO and ESMO, and certain genitourinary-specific conferences such as ASCO GU. ONCrg Conference keeps pace with the entire RCC landscape, which is changing rapidly given development of novel targeted therapies.   More

Competitive Landscape Analysis:

ONCrg Pipeline Strategies provide a comprehensive view of the entire competitive landscape, profiling drugs in Phase I/II development and beyond with valuable analytics by agent class and clinical status. Updated reports including treatment algorithms and drug profiles are delivered quarterly in order to stay current on the rapidly evolving RCC landscape.   More

Monthly Surveillance Reports:

ONCrg Sentinel provides vigilant monitoring of dynamic scientific, clinical, and commercial activities in RCC. ONCrg experts deliver incisive commentaries on current news events to inform subscribers each month, preparing them to respond wisely to ever-changing market conditions.   More